It was reported that on (b)(6) 2012, three stents were implanted.A 3.0x28mm xience prime was implanted in the proximal to mid left anterior descending artery.A non-abbott stent was implanted in the distal circumflex.After pre-dilatation was performed a 2.75x38 mm xience prime was implanted in the posterior lateral artery.On (b)(6) 2012, the patient was discharged from hospital.On (b)(6) 2013, the patient developed stable angina and in-stent restenosis of the 2.75x38 mm xience prime stent in the posterior lateral was confirmed on angiography.No treatment was performed.On (b)(6) 2014, revascularization was performed to treat the lesion and the stenosis was reduced from 99% to 0% after dilatation with a balloon catheter.On (b)(6) the symptoms had resolved.No additional information was provided.
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Stenosis, angina and prolonged hospitalization are listed in the xience prime everolimus eluting coronary stent systems instructions for use (ifu) as known patient effects of coronary stenting procedures.Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.
|